Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

18.02
Delayed Data
As of Jul 31
 +0.12 / +0.67%
Today’s Change
5.34
Today|||52-Week Range
19.43
+195.41%
Year-to-Date

Today’s Trading

Previous close17.90
Today’s open16.97
Day’s range16.80 - 18.78
Volume961,998
Average volume (3 months)1,916,618
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+18.40%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book20.45

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.52+0.93%
MCRBSeres Therapeutics I...-0.18-0.47%
MNTAMomenta Pharmaceutic...-0.01-0.05%
ESPREsperion Therapeutic...-2.25-3.50%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts